2 months ago
IMVT
AnalystsDerek ArchilaDerek Archila's Stock Forecasts
AnalystsDerek Archila
Analyst Ranking
Top 2%
#53 out of 4420 analysts
Average Return
+39.73%
Win Rate
53%39 out of 74
Risk vs Reward
Poor
Good
Derek Archila's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +1,563.62% | $0.87 | $14.54 | 2022-09-13 - 2023-09-13 | Strong Buy |
Prometheus Biosciences IncRXDX | +604.58% | $27.52 | $193.90 | 2022-05-12 - 2023-05-12 | Strong Buy |
Prometheus Biosciences IncRXDX | +294.01% | $50.74 | $199.92 | 2022-08-28 - 2023-06-15 | Strong Buy |
Prometheus Biosciences IncRXDX | +185.97% | $33.50 | $95.80 | 2021-12-07 - 2022-12-07 | Strong Buy |
Ngm Biopharmaceuticals IncNGM | +167.08% | $11.30 | $30.18 | 2020-03-18 - 2021-03-19 | Strong Buy |
Derek Archila Analyst Color
Get additional color on Derek Archila's coverage of popular stocks
3 months ago
CABA
3 months ago
APLS
4 months ago
ARGX
4 months ago
IMVT
7 months ago
MORF
a year ago
CABA
a year ago
ASND
a year ago
IMVT
a year ago
ARGX
a year ago
ASND
a year ago
RXDX
2 years ago
ARGX
Derek Archila's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kezar Life Sciences IncKZR | 8 | Hold | $2.00 | +133.92% | Maintains | 22 days ago |
Celldex Therapeutics IncCLDX | 2 | Hold | $27.00 | -14.75% | Upgrades | a month ago |
Rhythm Pharmaceuticals IncRYTM | 2 | Strong Buy | $40.00 | +8.67% | Maintains | a month ago |
Immunovant IncIMVT | 8 | Strong Buy | $48.00 | +20.21% | Maintains | 2 months ago |
Cabaletta Bio IncCABA | 4 | Strong Buy | $39.00 | +149.52% | Maintains | 3 months ago |
Apellis Pharmaceuticals IncAPLS | 5 | Strong Buy | $64.00 | -1.27% | Upgrades | 3 months ago |
Ascendis Pharma AASND | 7 | Strong Buy | $134.00 | +26.87% | Maintains | 3 months ago |
Zentalis Pharmaceuticals IncZNTL | 2 | Strong Buy | $50.00 | +329.18% | Maintains | 4 months ago |
Argenx SeARGX | 4 | Strong Buy | $609.00 | +32.52% | Maintains | 4 months ago |
Dice Therapeutics IncDICE | 2 | Hold | $48.00 | +0.95% | Maintains | 6 months ago |
Morphosys AgMOR | 1 | Strong Buy | $17.00 | +124.27% | Initiates Coverage On | 6 months ago |
Blueprint Medicines CorpBPMC | 5 | Hold | $55.00 | -24.98% | Maintains | 6 months ago |
Morphic Holding IncMORF | 5 | Strong Buy | $80.00 | +219.23% | Maintains | 7 months ago |
Zymeworks IncZYME | 1 | Strong Buy | $12.00 | +33.19% | Assumes | 9 months ago |
Ventyx Biosciences IncVTYX | 1 | Strong Buy | $77.00 | +3,549.29% | Initiates Coverage On | 9 months ago |
Exelixis IncEXEL | 1 | Strong Buy | $23.00 | +5.17% | Initiates Coverage On | 9 months ago |
Kymera Therapeutics IncKYMR | 4 | Strong Buy | $42.00 | +103.78% | Maintains | a year ago |
Incyte CorpINCY | 3 | Hold | $75.00 | +36.81% | Maintains | a year ago |
C4 Therapeutics IncCCCC | 3 | Hold | $9.00 | +508.11% | Maintains | a year ago |
Arvinas IncARVN | 2 | Hold | $49.00 | +111.48% | Downgrades | a year ago |
Monte Rosa Therapeutics IncGLUE | 2 | Strong Buy | $19.00 | +522.95% | Upgrades | a year ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Hold | $116.50 | +0.17% | Downgrades | a year ago |
Prometheus Biosciences IncRXDX | 4 | Strong Buy | $71.00 | N/A | Maintains | a year ago |
Nurix Therapeutics IncNRIX | 3 | Strong Buy | $25.00 | N/A | Upgrades | 2 years ago |
Arena Pharmaceuticals IncARNA | 1 | Strong Buy | $71.00 | N/A | Initiates Coverage On | 2 years ago |
Esperion Therapeutics IncESPR | 1 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Lumos Pharma IncLUMO | 1 | Strong Buy | $24.00 | N/A | Upgrades | 3 years ago |
Momenta Pharmaceuticals IncMNTA | 2 | Hold | $52.50 | N/A | Downgrades | 3 years ago |
Principia Biopharma IncPRNB | 1 | Hold | $100.00 | N/A | Downgrades | 3 years ago |
Inventiva SaIVA | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Genfit SaGNFT | 1 | Strong Buy | N/A | N/A | Upgrades | 3 years ago |
Galapagos NvGLPG | 1 | Hold | $193.00 | N/A | Downgrades | 3 years ago |
Viela Bio IncVIE | 1 | Hold | $58.00 | N/A | Initiates Coverage On | 3 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $8.00 | N/A | Upgrades | 4 years ago |
Oneok IncOKE | 1 | Strong Buy | $41.00 | N/A | Reiterates | 4 years ago |
Amarin Corp PLCAMRN | 2 | Hold | $8.00 | N/A | Maintains | 4 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $32.00 | N/A | Maintains | 4 years ago |
Dbv Technologies SaDBVT | 2 | Hold | $6.00 | N/A | Downgrades | 4 years ago |
Vanda Pharmaceuticals IncVNDA | 4 | Hold | $29.00 | N/A | Downgrades | 5 years ago |
Heron Therapeutics IncHRTX | 2 | Buy | $50.00 | N/A | Maintains | 5 years ago |
Urogen Pharma LtdURGN | 1 | Buy | $51.00 | N/A | Maintains | 6 years ago |
Perrigo Co PLCPRGO | 1 | Buy | $88.00 | N/A | Initiates Coverage On | 6 years ago |
Pacira Biosciences IncPCRX | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.